Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone to prevent postoperative delirium in digestive surgery
jRCTs041240032Recruiting
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative delirium (POD) comparing Hydrocortisone with Placebo (2 arms). Primary endpoint: Incidence of postoperative delirium during the first 3 days after surgery. Started Jun 2024; status: recruiting.
02
Drugs
hydrocortisone
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on jRCTs041240032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240032.